Hereafter, “non-APL-like” NPM1m AML will refer to all NPM1m AML cases that express HLA-DR (these include cases with monocytic markers such as primarily CD64, as well as cases with no monocytic markers). The gene discussed is FCGR1A; the disease is acute promyelocytic leukemia.